Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MANOLLIA 50 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/MANOLLIA 50 MG CAPSULAS DURAS EFG

Approved

STANDARD

MANOLLIA 50 MG CAPSULAS DURAS EFG

Aristo Pharma Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 10, 2023
Approval ID: 1cfa2fb0690ca3b9
Company: Aristo Pharma Gmbh
Type: Standard

Approval Details

Approval Id: 1cfa2fb0690ca3b9
Drug Cima Aemps Name: MANOLLIA 50 MG CAPSULAS DURAS EFG
Register Number: 88772
Holder Company Name: Aristo Pharma Gmbh
Marketing Company Name: Aristo Pharma Iberia S.L.
Holder Company Detail Path: /organization/aristo-pharma-gmbh
Authorization Date: 2023-04-10
Dosage Form: CÁPSULA DURA
Dose: 50 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario. Psicótropos
Commercialized: No
Company Name: Aristo Pharma Gmbh
Company Detail Path: /organization/aristo-pharma-gmbh

Company Information

Pharmaceutical Company Name: Aristo Pharma GmbH
Country Name: Germany
Website: http://www.aristo-pharma.de

Active Ingredients

LISDEXANFETAMINA DIMESILATO

50 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 10, 2023

Approval ID

1cfa2fb0690ca3b9

Type

Standard

Back to CIMA-AEMPS Approvals